7.48
0.34 (4.76%)
| Penutupan Terdahulu | 7.14 |
| Buka | 7.21 |
| Jumlah Dagangan | 201,376 |
| Purata Dagangan (3B) | 514,417 |
| Modal Pasaran | 332,977,440 |
| Harga / Jualan (P/S) | 93.48 |
| Harga / Buku (P/B) | 1.08 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 27 Mar 2025 |
| Margin Operasi (TTM) | -11,659.43% |
| EPS Cair (TTM) | -7.26 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 79.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6.07% |
| Nisbah Semasa (MRQ) | 27.77 |
| Aliran Tunai Operasi (OCF TTM) | -67.47 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -25.69 M |
| Pulangan Atas Aset (ROA TTM) | -17.20% |
| Pulangan Atas Ekuiti (ROE TTM) | -27.05% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menurun | Menurun |
| Biotechnology (Global) | Menurun | Menurun | |
| Stok | Septerna, Inc. | Menurun | - |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | 2.0 |
| Purata | 1.13 |
|
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 6.81% |
| % Dimiliki oleh Institusi | 99.66% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 25.00 (Cantor Fitzgerald, 234.23%) | Beli |
| Median | 21.50 (187.43%) | |
| Rendah | 18.00 (Wells Fargo, 140.64%) | Pegang |
| Purata | 21.50 (187.43%) | |
| Jumlah | 1 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 9.84 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Cantor Fitzgerald | 16 May 2025 | 25.00 (234.22%) | Beli | 9.84 |
| Wells Fargo | 16 May 2025 | 18.00 (140.64%) | Pegang | 9.84 |
| 28 Mar 2025 | 11.00 (47.06%) | Pegang | 6.10 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 29 May 2025 | Pengumuman | Septerna to Present at Jefferies Global Healthcare Conference |
| 15 May 2025 | Pengumuman | Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results |
| 27 Mar 2025 | Pengumuman | Septerna Provides Corporate Overview and Reports Fourth Quarter and Full Year 2024 Financial Results |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |